Bahamas vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Bahamas
100.0%
in 2020
Kazakhstan
100.0%
in 2024
Bahamas rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Bahamas
- Kazakhstan
How they compare
Bahamas currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 5 times across 12 shared years of data; in 2007 it was Bahamas ahead.
Bahamas ranks 1st and Kazakhstan ranks 1st of 180 countries.
Across the 3 decades both report, Bahamas averaged higher in 1 and Kazakhstan in 1.
Head to head by decade
| Decade | Bahamas | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.0% | 49.3% | 24.7% | Bahamas |
| 2010s | 58.4% | 85.5% | 27.1% | Kazakhstan |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bahamas or Kazakhstan?
- Bahamas, at 100.0% against 100.0% in Kazakhstan as of 2020.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bahamas and Kazakhstan?
- 0.0%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Kazakhstan?
- 12 years are reported by both, from 2007 to 2020.
- How do Bahamas and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Bahamas ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.